Publication | Closed Access

A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects

Breast OncologyModified ThymosinCell DeathCell ProliferationBreast CancerAnti-cancer AgentTumor SuppressorRadiation OncologyMedicineCell BiologyTumor MicroenvironmentCancer ResearchCancer GrowthHealth Sciences